Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dick van Soolingen

Showing results (1-10 of 313) with videos related to

Pageof 32
Sort By:
The Lancet. Respiratory Medicine|April 11, 2014
Whole-genome sequencing of Mycobacterium tuberculosis as an epidemiological markerDick van Soolingen
Recent Patents on Anti-Infective Drug Discovery|August 4, 2015
A Novel Advanced Laboratory Diagnosis to Guide Tuberculosis Drug TherapyLeonard Amaral, Dick van Soolingen
Kekkaku : [Tuberculosis]|March 14, 2009
[Findings and ongoing research in the molecular epidemiology of tuberculosis]Dick van Soolingen, Kristin Kremer
BMC Infectious Diseases|January 27, 2019
The respiratory microbiota: new insights into pulmonary tuberculosisSetegn Eshetie, Dick van Soolingen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Editor's choice: Editorial commentary: Low level INH-resistant BCG: a sheep in wolf's clothing?Sandra M Arend, Dick van Soolingen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2015
Editorial commentary: genotyping of Mycobacterium tuberculosis in China and missing links in the chain of ongoing transmission of tuberculosisSandra M Arend, Dick van Soolingen
International Journal of Pediatric Otorhinolaryngology|March 8, 2011
Cervicofacial lymphadenitis caused by nontuberculous mycobacteria; host, environmental or bacterial factors?Jakko van Ingen, Dick van Soolingen
Current Pharmaceutical Design|August 13, 2011
Drug susceptibility testing for optimizing tuberculosis treatmentSami O Simons, Dick van Soolingen
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 10, 2011
DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencingAnita C Schürch, Dick van Soolingen
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2012
On the road to unravelling the aetiology of non-tuberculous mycobacterial diseaseDick van Soolingen, Jakko van Ingen
Pageof 32

Showing results (1-10 of 313) with videos related to

Sort By:
Pageof 32
The Lancet. Respiratory Medicine|April 11, 2014
Whole-genome sequencing of Mycobacterium tuberculosis as an epidemiological markerDick van Soolingen
Recent Patents on Anti-Infective Drug Discovery|August 4, 2015
A Novel Advanced Laboratory Diagnosis to Guide Tuberculosis Drug TherapyLeonard Amaral, Dick van Soolingen
Kekkaku : [Tuberculosis]|March 14, 2009
[Findings and ongoing research in the molecular epidemiology of tuberculosis]Dick van Soolingen, Kristin Kremer
BMC Infectious Diseases|January 27, 2019
The respiratory microbiota: new insights into pulmonary tuberculosisSetegn Eshetie, Dick van Soolingen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Editor's choice: Editorial commentary: Low level INH-resistant BCG: a sheep in wolf's clothing?Sandra M Arend, Dick van Soolingen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 2, 2015
Editorial commentary: genotyping of Mycobacterium tuberculosis in China and missing links in the chain of ongoing transmission of tuberculosisSandra M Arend, Dick van Soolingen
International Journal of Pediatric Otorhinolaryngology|March 8, 2011
Cervicofacial lymphadenitis caused by nontuberculous mycobacteria; host, environmental or bacterial factors?Jakko van Ingen, Dick van Soolingen
Current Pharmaceutical Design|August 13, 2011
Drug susceptibility testing for optimizing tuberculosis treatmentSami O Simons, Dick van Soolingen
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 10, 2011
DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencingAnita C Schürch, Dick van Soolingen
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2012
On the road to unravelling the aetiology of non-tuberculous mycobacterial diseaseDick van Soolingen, Jakko van Ingen
Pageof 32